covid-19 drug discovery with qualified cell-based assays for proinflammatory cytokines
Published 4 years ago • 826 plays • Length 24:50Download video MP4
Download video MP3
Similar videos
-
42:13
accelerating covid-19 drug discovery: qualified assays for proinflammatory cytokines
-
22:49
eurofins discovery pegs conference 2021 therapeutic interventions for covid-19
-
59:46
edrx webinar the value of gpcr cell based assays in drug discovery
-
12:58
eurofins discoverx internalization assays
-
25:26
discoverx cytotoxicity cell-based assays
-
33:27
combining target based and phenotypic discovery assays for drug repurposing
-
52:45
global anticancer drug discovery & development trends
-
1:00:38
cell based bioassays
-
22:37
komabiotech webinar - in vivo pharmacology and pk services - pharmacology discovery services (pds)
-
41:43
drug discovery, biotech, and ai with alex zhavoronkov, ceo, insilico medicine (cxotalk #327)
-
2:02
eurofins discovery: it all starts with biology
-
2:01
eurofins discovery: we know what it takes
-
14:21
covid-19 and the riddle of the sphinx: r&d portfolio: drug discovery
-
55:18
eurofins integrated drug discovery webinar
-
23:07
eurofins discovery biomarker services
-
30:07
antiviral drug discovery for covid-19, amrf webinar with dr dan furkert
-
22:58
eurofins discovery oncopanel
-
56:37
immuno-oncology drug development profiling immunomodulatory biologics and compounds